Today, a coalition of organizations supportive of medical marijuana patients and providers — including MPP, Drug Policy Alliance (DPA), NORML, California NORML, Law Enforcement Against Prohibition (LEAP), and Students for Sensible Drug Policy (SSDP) — is calling on President Obama to withdraw his nomination of Michele Leonhart to serve as administrator of the Drug Enforcement Administration (DEA).
The following is a from press release just sent out on behalf of the coalition:
Ms. Leonhart, who is currently the DEA’s acting-administrator, has not demonstrated that she is capable of leading the agency in a thoughtful manner at a time when 14 states have enacted medical marijuana laws and science is increasingly confirming the therapeutic benefits of the substance.
Under Leonhart’s leadership, the DEA has staged medical marijuana raids in apparent disregard of Attorney General Eric Holder’s directive to respect state medical marijuana laws. Most recently, DEA agents flouted a pioneering Mendocino County (CA) ordinance to regulate medical marijuana cultivation by raiding the very first grower to register with the sheriff. Joy Greenfield, 69, had paid more than $1,000 for a permit to cultivate 99 plants in a collective garden that had been inspected and approved by the local sheriff.
Informed that Ms. Greenfield had the support of the sheriff, the DEA agent in charge responded by saying, “I don’t care what the sheriff says.” The DEA’s conduct is inconsistent with an October 2009 Department of Justice memo directing officials not to arrest individuals “whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana.”
Ms. Leonhart has also demonstrated that she is unable to be objective in carrying out the duties of the administrator as it relates to medical marijuana research. In January 2009, she refused to issue a license to the University of Massachusetts to cultivate marijuana for FDA-approved research, despite a DEA administrative law judge’s ruling that it would be “in the public interest” to issue the license. This single act has blocked privately funded medical marijuana research in this country. The next DEA administrator will likely influence the outcome of a marijuana-rescheduling petition currently before the agency. It is critical that an administrator with an open mind toward science and research is at the helm.
“With Leonhart’s nomination pending, one would expect her to be more — not less — respectful of the Department of Justice and the rights of individuals in medical marijuana states,” said Steve Fox, director of government relations at the Marijuana Policy Project. “Such behavior is an ominous sign for the future of the DEA under her leadership. Moreover, she has continually demonstrated her desire to block privately funded medical marijuana research in this country. The Obama administration has reversed many Bush administration policies over the past 18 months. It is time to transform the culture at the DEA by either withdrawing Leonhart’s nomination or directing her to change her attitude toward medical marijuana.”